West Coast Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,133
Closed -$7.64M 117
2025
Q1
$7.64M Sell
34,133
-1,205
-3% -$281K 0.87% 33
2024
Q4
$8.08M Sell
35,338
-152
-0.4% -$36.6K 0.89% 38
2024
Q3
$8.66M Sell
35,490
-350
-1% -$78.2K 0.95% 35
2024
Q2
$6.86M Sell
35,840
-536
-1% -$109K 0.81% 42
2024
Q1
$7.2M Sell
36,376
-416
-1% -$76.2K 0.87% 41
2023
Q4
$6.33M Buy
36,792
+3,139
+9% +$482K 0.83% 43
2023
Q3
$4.98M Buy
33,653
+100
+0.3% +$18.1K 0.74% 54
2023
Q2
$7.33M Sell
33,553
-493
-1% -$110K 1.04% 27
2023
Q1
$7.46M Buy
34,046
+224
+0.7% +$48.6K 1.14% 25
2022
Q4
$7.04M Sell
33,822
-581
-2% -$128K 1.19% 21
2022
Q3
$7.51M Buy
34,403
+362
+1% +$82.4K 1.38% 19
2022
Q2
$7.14M Sell
34,041
-136
-0.4% -$29K 1.27% 23
2022
Q1
$8.29M Buy
34,177
+141
+0.4% +$34.1K 1.27% 28
2021
Q4
$8.87M Sell
34,036
-370
-1% -$96K 1.27% 28
2021
Q3
$9.07M Sell
34,406
-279
-0.8% -$76.3K 1.46% 18
2021
Q2
$8.55M Buy
34,685
+207
+0.6% +$43.5K 1.39% 22
2021
Q1
$6.69M Buy
34,478
+187
+0.5% +$37.5K 1.16% 30
2020
Q4
$7.29M Sell
34,291
-13,151
-28% -$2.62M 1.4% 24
2020
Q3
$8.13M Sell
47,442
-1,072
-2% -$198K 1.84% 12
2020
Q2
$9.31M Sell
48,514
-301
-0.6% -$49.2K 2.27% 8
2020
Q1
$7.19M Buy
48,815
+69
+0.1% +$11K 1.91% 17
2019
Q4
$7.55M Sell
48,746
-919
-2% -$132K 1.61% 23
2019
Q3
$6.71M Buy
49,665
+450
+0.9% +$59K 1.52% 26
2019
Q2
$6.01M Sell
49,215
-1,266
-3% -$140K 1.37% 27
2019
Q1
$5.25M Buy
50,481
+2,152
+4% +$222K 1.24% 29
2018
Q4
$5.5M Sell
48,329
-1,884
-4% -$202K 1.56% 21
2018
Q3
$5.79M Sell
50,213
-31,632
-39% -$3.46M 1.34% 25
2018
Q2
$8.48M Sell
81,845
-243
-0.3% -$24.6K 2.34% 11
2018
Q1
$8.08M Buy
82,088
+275
+0.3% +$26K 2.31% 11
2017
Q4
$6.93M Buy
81,813
+1,250
+2% +$103K 1.95% 14
2017
Q3
$6.2M Buy
80,563
+1,932
+2% +$148K 1.68% 15
2017
Q2
$6.12M Buy
78,631
+4,477
+6% +$320K 1.96% 13
2017
Q1
$5.34M Sell
74,154
-533
-0.7% -$36.8K 1.7% 19
2016
Q4
$4.63M Buy
74,687
+70
+0.1% +$4.29K 1.47% 21
2016
Q3
$4.83M Sell
74,617
-1,132
-1% -$75.3K 1.55% 21
2016
Q2
$4.79M Buy
75,749
+933
+1% +$55K 1.73% 22
2016
Q1
$4.33M Buy
74,816
+862
+1% +$48.8K 1.78% 22
2015
Q4
$3.97M Sell
73,954
-1,766
-2% -$99.5K 1.66% 20
2015
Q3
$3.86M Sell
75,720
-141
-0.2% -$7.59K 1.72% 20
2015
Q2
$4.28M Buy
75,861
+7,554
+11% +$477K 1.88% 18
2015
Q1
$4.9M Buy
68,307
+2,850
+4% +$185K 2.28% 10
2014
Q4
$3.67M Sell
65,457
-373
-0.6% -$19.5K 1.9% 23
2014
Q3
$3.24M Buy
65,830
+1,170
+2% +$59.6K 1.83% 25
2014
Q2
$3.27M Sell
64,660
-305
-0.5% -$15.1K 1.72% 26
2014
Q1
$2.9M Sell
64,965
-8,376
-11% -$376K 1.47% 34
2013
Q4
$3.45M Sell
73,341
-3,254
-4% -$165K 1.78% 19
2013
Q3
$4.05M Sell
76,595
-2,910
-4% -$141K 2.24% 5
2013
Q2
$3.59M Buy
+79,505
New +$3.77M 1.96% 8

Other funds holding RMD

West Coast Financial's RMD Position: Q2 2025 in Review

West Coast Financial sold out of ResMed (RMD) in Q2 2025, closing a stake of 34,133 shares — an estimated $7.64M sold.

West Coast Financial first reported a position in RMD in Q2 2013 and held it in 48 quarters. The position peaked at $9.31M in Q2 2020. 920 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • West Coast Financial reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • West Coast Financial sold 34,133 ResMed shares in Q2 2025, an estimated $7.64M.
  • West Coast Financial first reported a position in ResMed in Q2 2013 and held it in 48 quarters.
  • West Coast Financial's ResMed position peaked at $9.31M in Q2 2020.
  • 920 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on West Coast Financial's 13F filing for Q2 2025.